Core Insights - Axon Enterprise, Inc. is a leading developer of advanced technology and weapons products for law enforcement and military use, with a market cap of $41.2 billion [1] Financial Performance - Axon has underperformed the broader market, with stock prices declining 12.2% year-to-date and 17.3% over the past 52 weeks, while the S&P 500 Index gained 12.3% in 2025 and 11% over the past year [2] - The company also lagged behind the Industrial Select Sector SPDR Fund, which saw a 13.6% increase year-to-date and a 6.4% rise over the past year [3] - Following the release of Q3 results on November 4, Axon's stock prices fell 9.4%. The company reported a 6.3% year-over-year revenue growth to $710.6 million, exceeding expectations by 1.6%. However, adjusted EPS dropped 44.8% to $1.17, missing consensus estimates by 28.2% [4] Earnings Outlook - For the full fiscal year 2025, analysts project an adjusted EPS of $0.18, representing a 91.4% decline year-over-year. The company has a mixed earnings surprise history, surpassing estimates twice and missing them twice in the past four quarters [5] - Among 20 analysts covering Axon, the consensus rating is a "Strong Buy," with 13 "Strong Buys," four "Moderate Buys," and three "Holds" [5] Analyst Ratings - Barclays analyst Tim Long maintained a "Buy" rating on Axon but reduced the price target from $861 to $702. The mean price target of $811.47 indicates a 55.5% premium to current price levels, while the highest target of $925 suggests a potential upside of 77.2% [6]
Axon Enterprise Stock Outlook: Is Wall Street Bullish or Bearish?